Thoracoacromial artery and vein as main recipient vessels in deep inferior epigastric artery perforator (DIEP) flap transfer for breast reconstruction

医学 腹壁下动脉穿支皮瓣 乳房再造术 吻合 外科 静脉 动脉 乳腺癌 癌症 内科学
作者
Takumi Yamamoto,Takashi Kageyama,Hayahito Sakai,Yuma Fuse,Reiko Tsukuura,Naoki Yamamoto
出处
期刊:Journal of Surgical Oncology [Wiley]
卷期号:123 (5): 1232-1237 被引量:5
标识
DOI:10.1002/jso.26421
摘要

Abstract Background The internal mammary artery/vein (IMA/V) are commonly used recipients for free flap breast reconstruction, but requires costal cartilage resection and limits future use of the IMA. This study aimed to evaluate the feasibility of the thoracoacromial artery/vein (TAA/V) as recipients for deep inferior epigastric artery perforator (DIEP) flap breast reconstruction compared with using the IMA/V. Methods Medical charts of patients who underwent free DIEP flap breast reconstruction using the TAA/V or the IMA/V as recipient vessels were reviewed. Patient and vessel characteristics, time for vessel preparation and anastomosis, and postoperative pain were compared between TAA/V and IMA/V groups. Results Thirty‐four patients were included; 12 in TAA/V group, and 22 in IMA/V group. There was no flap failure in both groups. There were statistically significant differences between TAA/V and IMA/V groups in vessel preparation time (10.9 ± 3.7 min vs. 24.1 ± 6.0 min, p < .001), anastomosis time (31.2 ± 12.1 min vs. 42.1 ± 11.2 min, p = .017), and total dose of acetaminophen (4566.7 ± 1015.6 mg vs. 5436.4 ± 1323.3 mg, p = .041). Conclusions The TAA/V could be safely used as recipient vessels for DIEP flap breast reconstruction with shorter time and less postoperative pain.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
852应助彩色德天采纳,获得10
刚刚
Chelsea完成签到,获得积分10
刚刚
幽兰发布了新的文献求助20
1秒前
1秒前
上官若男应助小二采纳,获得10
1秒前
1秒前
1秒前
WHTTTTT发布了新的文献求助10
2秒前
潇洒愚志完成签到,获得积分10
2秒前
lele发布了新的文献求助50
2秒前
2秒前
4秒前
我是老大应助燕子采纳,获得30
4秒前
heli发布了新的文献求助10
5秒前
5秒前
6秒前
淀粉肠发布了新的文献求助10
7秒前
科研通AI6.1应助lulu采纳,获得10
8秒前
lai完成签到,获得积分10
9秒前
桐桐应助科研通管家采纳,获得10
9秒前
9秒前
桐桐应助科研通管家采纳,获得10
9秒前
9秒前
9秒前
隐形曼青应助科研通管家采纳,获得10
9秒前
9秒前
搜集达人应助科研通管家采纳,获得10
9秒前
隐形曼青应助科研通管家采纳,获得10
9秒前
英姑应助科研通管家采纳,获得10
10秒前
搜集达人应助科研通管家采纳,获得10
10秒前
彭于晏应助科研通管家采纳,获得10
10秒前
英姑应助科研通管家采纳,获得10
10秒前
彭于晏应助科研通管家采纳,获得10
10秒前
10秒前
10秒前
瑶瑶大王应助科研通管家采纳,获得20
10秒前
瑶瑶大王应助科研通管家采纳,获得20
10秒前
王伟轩应助科研通管家采纳,获得10
10秒前
王伟轩应助科研通管家采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Les Mantodea de guyane 2500
VASCULITIS(血管炎)Rheumatic Disease Clinics (Clinics Review Articles) —— 《风湿病临床》(临床综述文章) 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
What is the Future of Psychotherapy in a Digital Age? 801
The Psychological Quest for Meaning 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5971712
求助须知:如何正确求助?哪些是违规求助? 7288942
关于积分的说明 15992394
捐赠科研通 5109548
什么是DOI,文献DOI怎么找? 2744066
邀请新用户注册赠送积分活动 1709783
关于科研通互助平台的介绍 1621760